These effects, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the concept of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. The positioning is safe. https://teimumuf604lbm0.plpwiki.com/user